EVERSANA Announces Real-World Data Agreement with Janssen to Augment Development of Chronic Disease Care Therapies

CHICAGO EVERSANA , the pioneer of next generation services to the global life sciences industry, today announced an agreement with Janssen Research & Development, LLC (Janssen) to transform clinical data into the much-needed evolution of chronic disease care through real-word data (RWD), data science analysis and regulatory-grade studies.

Read the source article at PR Newswire
2021-12-16 17:00:00